EOLS Stock Analysis: Buy, Sell, or Hold?
EOLS - Evolus, Inc. Common Stock
$8.39
0.04 (0.48%)
▲
5d:
+2.88%
30d:
+40.07%
90d:
+30.08%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 05, 2026
0d
Get Alerted When EOLS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: EOLS shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: EOLS shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$9.67
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$6.00
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: EOLS is currently trading at $8.39, which is considered extended relative to its 30-day fair value range of $5.77 to $7.92. The stock's valuation (Forward PE: 30.4) is in line with its historical norms (29.0). At these levels, the market is pricing in 1.5% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, EOLS is in a strong uptrend. Immediate support is located at $7.18, while resistance sits at $8.69.
Market Sentiment: EOLS scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $15.00 (+78.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, EOLS is in a strong uptrend. Immediate support is located at $7.18, while resistance sits at $8.69.
Market Sentiment: EOLS scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $15.00 (+78.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$5.77 -
$7.92
Company Quality Score
27/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
39.2%
Protect Your Profits
Holding EOLS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+5.9% above its trading range)
- BULLISH: Options cheap (IV 0th percentile)
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 78.8% below Wall St target ($15.00)
- NEUTRAL: Market pricing in 1.5% annual earnings growth - fairly valued
- WARNING: Composite score 27/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$5.77 -
$7.92
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$0.83
(9.9%)
Support & Resistance Levels
Support Level
$7.18
Resistance Level
$8.69
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
30.40
Wall Street Target
$15.00
(+78.8%)
Revenue Growth (YoY)
21.2%
Profit Margin
-10.8%
Valuation Premium vs History
+1.5% premium
PE vs Historical
30.4 vs 29.0
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+1.5%
(market-implied from PE analysis)
1-Year Target
$8.52
(+2%)
2-Year Target
$8.64
(+3%)
3-Year Target
$8.77
(+5%)
3-Yr Target (if PE normalizes)
(PE: 30→29)
PE COMPRESSION
$8.37
(0%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: August 23, 2026 9:19 PM ET
Data refreshes hourly during market hours. Next update: 10:19 PM
Data refreshes hourly during market hours. Next update: 10:19 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is EOLS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
David Moatazedi
SELL
13669 shares
2026-03-20
Rui Avelar
SELL
3119 shares
2026-03-20
David Moatazedi
SELL
116720 shares
2026-03-17
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$212 | 67 BUY |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$107 | 56 HOLD |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$101 | 43 HOLD |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$664 | 48 HOLD |
|
LQDA
Liquidia Technologies Inc |
STRONG BUY
10 analysts |
$108 | 55 HOLD |
Advanced EOLS Option Strategies
Professional options setups generated by AI based on today's EOLS price and gamma walls.
